Aurobindo Pharma is currently trading at Rs. 841.55, up by 23.55 points or 2.88% from its previous closing of Rs. 818.00 on the BSE.
The scrip opened at Rs. 847.90 and has touched a high and low of Rs. 850.80 and Rs. 836.55 respectively. So far shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 967.60 on 10-Aug-2020 and a 52 week low of Rs. 281.15 on 23-Mar-2020.
Last one week high and low of the scrip stood at Rs. 850.80 and Rs. 791.00 respectively. The current market cap of the company is Rs. 47929.78 crore.
The promoters holding in the company stood at 52.01%, while Institutions and Non-Institutions held 35.19% and 12.80% respectively.
Aurobindo Pharma has collaborated with the Council of Scientific and Industrial Research (CSIR) to develop vaccines to protect against SARS-CoV-2, also known as COVID-19. Under the signed agreement between CSIR-Centre for Cellular and Molecular Biology (CCMB) and Aurobindo Pharma, Aurobindo will partner with CSIR for development of several novel COVID-19 vaccines. Three CSIR labs namely CCMB Hyderabad, Institute of Medical Technology (IMTECH), Chandigarh and Indian Institute of Chemical Biology (IICB), Kolkata are developing vaccine candidates using different technology platforms. Aurobindo will undertake clinical development and commercialization of the vaccines.
Apart from this collaboration, Aurobindo is already developing a vaccine for SARS COV-2 through its wholly owned US subsidiary Auro Vaccines. The SARS COV-2 vaccine candidate is based on the company’s proprietary replication-competent, attenuated, recombinant vesicular stomatitis (VSV, VesiculoVax) vaccine delivery platform.
Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments.
Watch our Stock Market Target Calls Quality, Track sheet – Click Here or Subscribe us for Stock Market Trading >>>> Stock Cash Tips
No comments:
Post a Comment